These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32321148)

  • 1. Estimating risk in clinical studies: odds ratio and risk ratio.
    Furcada JM; Patino CM; Ferreira JC
    J Bras Pneumol; 2020 Apr; 46(2):e20200137. PubMed ID: 32321148
    [No Abstract]   [Full Text] [Related]  

  • 2. [Down with odds ratios: risk ratios in cohort studies and randomised clinical trials].
    Knol MJ
    Ned Tijdschr Geneeskd; 2012; 156(28):A4775. PubMed ID: 22805792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the relative risk in cohort studies and clinical trials of common outcomes.
    McNutt LA; Wu C; Xue X; Hafner JP
    Am J Epidemiol; 2003 May; 157(10):940-3. PubMed ID: 12746247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: "Estimating the relative risk in cohort studies and clinical trials of common outcomes".
    Karp I
    Am J Epidemiol; 2014 Apr; 179(8):1034-5. PubMed ID: 24553682
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: "Estimating the relative risk in cohort studies and clinical trials of common outcomes".
    Deddens JA; Petersen MR
    Am J Epidemiol; 2004 Jan; 159(2):213-4; author reply 214-5. PubMed ID: 14718224
    [No Abstract]   [Full Text] [Related]  

  • 6. On logistic regression analysis of dichotomized responses.
    Lu K
    Pharm Stat; 2017 Jan; 16(1):55-63. PubMed ID: 27580937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating adjusted NNT measures in logistic regression analysis.
    Bender R; Kuss O; Hildebrandt M; Gehrmann U
    Stat Med; 2007 Dec; 26(30):5586-95. PubMed ID: 17879268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical note: The risk ratio, an alternative to the odds ratio for estimating the association between multiple risk factors and a dichotomous outcome.
    Ospina PA; Nydam DV; DiCiccio TJ
    J Dairy Sci; 2012 May; 95(5):2576-84. PubMed ID: 22541486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which statistical tests for estimating osteoporotic fracture risk?
    Wendlova J
    Bratisl Lek Listy; 2006; 107(11-12):453-8. PubMed ID: 17425166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical methods of estimating fracture risk.
    Wendlová J
    Wien Med Wochenschr; 2006 Nov; 156(21-22):569-73. PubMed ID: 17160373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Odds Ratios-Current Best Practice and Use.
    Norton EC; Dowd BE; Maciejewski ML
    JAMA; 2018 Jul; 320(1):84-85. PubMed ID: 29971384
    [No Abstract]   [Full Text] [Related]  

  • 12. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes.
    Zhang J; Yu KF
    JAMA; 1998 Nov; 280(19):1690-1. PubMed ID: 9832001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of Carotid Revascularization Endarterectomy versus Stent Trial (CREST) and Centers for Medicare and Medicaid Services Carotid Guideline Publication on utilization and outcomes of carotid stenting among "high-risk" patients.
    Salzler GG; Farber A; Rybin DV; Doros G; Siracuse JJ; Eslami MH
    J Vasc Surg; 2017 Jul; 66(1):104-111.e1. PubMed ID: 28502543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining risk difference and risk ratio in noninferiority trials of safety.
    Broglio KR; Connor JT; Berry SM
    J Biopharm Stat; 2013; 23(1):261-71. PubMed ID: 23331235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Logistic regression was preferred to estimate risk differences and numbers needed to be exposed adjusted for covariates.
    Gehrmann U; Kuss O; Wellmann J; Bender R
    J Clin Epidemiol; 2010 Nov; 63(11):1223-31. PubMed ID: 20430578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the relative recurrence risk ratio using a global cross-ratio model.
    Wallace C; Clayton D
    Genet Epidemiol; 2003 Dec; 25(4):293-302. PubMed ID: 14639699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and outcomes of reinterventions in Food and Drug Administration-approved versus trial endovascular aneurysm repair devices.
    Fairman AS; Wang GJ; Jackson BM; Foley PJ; Damrauer SM; Kalapatapu V; Golden MA; Fairman RM
    J Vasc Surg; 2018 Apr; 67(4):1082-1090. PubMed ID: 29074115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials.
    Brand R; Kragt H
    Stat Med; 1992 Dec; 11(16):2077-82. PubMed ID: 1293669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk and odds--how to calculate with events].
    Malmquist J
    Lakartidningen; 2002 Feb; 99(8):751-3, 756. PubMed ID: 11894612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.